A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)

J1I-MC-GZBB -

The main purpose of this study is to learn about the side effects of LY3437943 when given to participants with type 2 diabetes. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Each enrolled participant will receive injections of LY3437943, dulaglutide, or placebo given just under the skin.

Trial Summary

Age Range
20 - 70 years
Conditions the trial is for
Type 2 Diabetes
What the trial is testing?
Dulaglutide, LY3437943
Could I receive a Placebo?
Yes
Enrollment Goal
72
Trial Dates
Dec 18, 2019 - Dec 28, 2020
How long will I be in the trial?
The study will last up to about 5 months and will include 16 visits to the study center.
Trial Phase
I

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Participants must be diagnosed with type 2 diabetes for at least six months

  • Participants must have stable body weight for the last 3 months

  • Participants must be overweight or very overweight

  • Male participants must agree to use birth control during the study and for 90 days afterward and female participants must not be able to get pregnant

Participants Must Not:

  • Participants must not have known complication of diabetes

  • Participants must not have Type 1 diabetes mellitus

  • Participants must not have uncontrolled diabetes, (meaning that they required hospitalization for treatment of life-threatening complications of diabetes in the last six months)

  • Participants must not have had severe low blood sugar requiring emergency treatment

  • Participants must not have inflammation of the pancreas

  • Participants must not have known liver disease

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.